This content is machine translated Advanced renal cell carcinoma New points of attack under the microscope Even in the era of VEGF and checkpoint inhibitors, the prognosis for advanced renal cell carcinoma remains poor. The use of targeted therapies and immunotherapeutic approaches is difficult due to…
